112 related articles for article (PubMed ID: 26222086)
1. Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.
Hudler P; Kocevar N; Komel R
ScientificWorldJournal; 2014; 2014():260348. PubMed ID: 24550697
[TBL] [Abstract][Full Text] [Related]
2. Tumor biomarkers for diagnosis, prognosis and targeted therapy.
Zhou Y; Tao L; Qiu J; Xu J; Yang X; Zhang Y; Tian X; Guan X; Cen X; Zhao Y
Signal Transduct Target Ther; 2024 May; 9(1):132. PubMed ID: 38763973
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and biomarkers in clinical trials for drug development.
Lee JM; Han JJ; Altwerger G; Kohn EC
J Proteomics; 2011 Nov; 74(12):2632-41. PubMed ID: 21570499
[TBL] [Abstract][Full Text] [Related]
4. The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers.
Srivastava S; Wagner PD
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2401-2410. PubMed ID: 32357955
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Proteomics Approaches for Translational Research and HIV-Associated Malignancy Mechanisms.
Alvarez-Rivera E; Ortiz-Hernández EJ; Lugo E; Lozada-Reyes LM; Boukli NM
Proteomes; 2023 Jul; 11(3):. PubMed ID: 37489388
[TBL] [Abstract][Full Text] [Related]
6. Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned.
Li G; Bankhead P; Dunne PD; O'Reilly PG; James JA; Salto-Tellez M; Hamilton PW; McArt DG
Brief Bioinform; 2017 Jul; 18(4):634-646. PubMed ID: 27255914
[TBL] [Abstract][Full Text] [Related]
7. Proteomics and Its Applications in Cancers 2.0.
Naryzhny S
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674032
[TBL] [Abstract][Full Text] [Related]
8. Senescence program and its reprogramming in pancreatic premalignancy.
Yang K; Li X; Xie K
Cell Death Dis; 2023 Aug; 14(8):528. PubMed ID: 37591827
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis.
Baldan-Martin M; Chaparro M; Gisbert JP
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373307
[TBL] [Abstract][Full Text] [Related]
10. Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study.
Lima T; Barros AS; Trindade F; Ferreira R; Leite-Moreira A; Barros-Silva D; Jerónimo C; Araújo L; Henrique R; Vitorino R; Fardilha M
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454907
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer Recurrence Risk Assessment: Is Non-Invasive Monitoring an Option?
Schunkert EM; Zhao W; Zänker K
Biomed Hub; 2018; 3(3):1-17. PubMed ID: 31988964
[TBL] [Abstract][Full Text] [Related]
12. Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer.
Jedinak A; Loughlin KR; Moses MA
Oncotarget; 2018 Aug; 9(65):32534-32550. PubMed ID: 30197761
[TBL] [Abstract][Full Text] [Related]
13. Urinary kallikrein 10 predicts the incurability of gastric cancer.
Shimura T; Ebi M; Yamada T; Yamada T; Katano T; Nojiri Y; Iwasaki H; Nomura S; Hayashi N; Mori Y; Kataoka H; Moses MA; Joh T
Oncotarget; 2017 Apr; 8(17):29247-29257. PubMed ID: 28418926
[TBL] [Abstract][Full Text] [Related]
14. Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases.
Chen Z; Kim J
BMC Urol; 2016 Mar; 16():11. PubMed ID: 27000794
[TBL] [Abstract][Full Text] [Related]
15. Mining the Human Proteome: Biomarker Discovery for Human Cancer and Metastases.
Yang J; Roy R; Jedinak A; Moses MA
Cancer J; 2015; 21(4):327-36. PubMed ID: 26222086
[TBL] [Abstract][Full Text] [Related]
16. Metastatic biomarker discovery through proteomics.
Brinton LT; Brentnall TA; Smith JA; Kelly KA
Cancer Genomics Proteomics; 2012 Nov; 9(6):345-55. PubMed ID: 23162074
[TBL] [Abstract][Full Text] [Related]
17. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
[TBL] [Abstract][Full Text] [Related]
18. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
19. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
